Image of Hematology

Split Viewer

Blood Res 2022; 57(2):

Published online June 30, 2022

https://doi.org/10.5045/br.2022.2020113

© The Korean Society of Hematology

Smudge cells in CD200+, TP53 mutated leukemic mantle cell lymphoma

Preetesh Jain1, Xin Han2, Michael Wang1, Guilin Tang3

1Department of Lymphoma and Myeloma, 2Department of Laboratory Medicine, 3Department of Hematopathology, The University of Texas, M.D. Anderson Cancer Center, Houston, TX, USA

Correspondence to : Guilin Tang, M.D., Department of Hematopathology, The University of Texas, M.D. Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA, E-mail: GTang@mdanderson.org

Received: May 16, 2020; Revised: April 29, 2022; Accepted: May 9, 2022

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

A 71-year-old man presented with progressively increasing lymphocyte count since the last 12 months. Physical examination was unremarkable. Laboratory studies showed a hemoglobin 13.1 g/dL, leukocytosis of 71.4 K/µL, lymphocyte count of 67.5 K/µL and platelets 172 K/µL. Other tests including whole body PET-CT scan were unremarkable. Peripheral blood smear showed lymphocytosis increased “smudge cells” (A, inset showing smudge cells). Smudge cells were 45% of the total white blood cells. Bone marrow (BM) aspiration and biopsy demonstrated small lymphocytic infiltration with 70% cellularity. Immunohistochemical stains were positive for Cyclin D1 and negative for SOX11. Complex karyotype was detected. FISH studies were positive for IGH/CCND1 and a deletion of TP53. Flow cytometry demonstrated a kappa restricted–monotypic B cell population which was positive for CD5, CD19, CD20, CD22, CD23, CD79b, CD200 (dim), and FMC-7; and negative for CD43 (B). Next generation sequencing based analysis showed TP53 mutation NM_000546.5(TP53):c.389T>A p.L130H. Presence of smudge cells and immunophenotype suggested an initial diagnosis of CLL (chronic lymphocytic leukemia). The smudge cells in this patient were morphologically very similar to typical CLL. Smudge formation in clonal cells is rare in mantle cell lymphoma. Because of the presence of CCND1 gene rearrangement and cyclin D1 positive monoclonal B lymphoma cells in the BM, a diagnosis of leukemic phase of a small cell variant of mantle cell lymphoma was rendered.

Article

Image of Hematology

Blood Res 2022; 57(2): 85-85

Published online June 30, 2022 https://doi.org/10.5045/br.2022.2020113

Copyright © The Korean Society of Hematology.

Smudge cells in CD200+, TP53 mutated leukemic mantle cell lymphoma

Preetesh Jain1, Xin Han2, Michael Wang1, Guilin Tang3

1Department of Lymphoma and Myeloma, 2Department of Laboratory Medicine, 3Department of Hematopathology, The University of Texas, M.D. Anderson Cancer Center, Houston, TX, USA

Correspondence to:Guilin Tang, M.D., Department of Hematopathology, The University of Texas, M.D. Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA, E-mail: GTang@mdanderson.org

Received: May 16, 2020; Revised: April 29, 2022; Accepted: May 9, 2022

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Body

A 71-year-old man presented with progressively increasing lymphocyte count since the last 12 months. Physical examination was unremarkable. Laboratory studies showed a hemoglobin 13.1 g/dL, leukocytosis of 71.4 K/µL, lymphocyte count of 67.5 K/µL and platelets 172 K/µL. Other tests including whole body PET-CT scan were unremarkable. Peripheral blood smear showed lymphocytosis increased “smudge cells” (A, inset showing smudge cells). Smudge cells were 45% of the total white blood cells. Bone marrow (BM) aspiration and biopsy demonstrated small lymphocytic infiltration with 70% cellularity. Immunohistochemical stains were positive for Cyclin D1 and negative for SOX11. Complex karyotype was detected. FISH studies were positive for IGH/CCND1 and a deletion of TP53. Flow cytometry demonstrated a kappa restricted–monotypic B cell population which was positive for CD5, CD19, CD20, CD22, CD23, CD79b, CD200 (dim), and FMC-7; and negative for CD43 (B). Next generation sequencing based analysis showed TP53 mutation NM_000546.5(TP53):c.389T>A p.L130H. Presence of smudge cells and immunophenotype suggested an initial diagnosis of CLL (chronic lymphocytic leukemia). The smudge cells in this patient were morphologically very similar to typical CLL. Smudge formation in clonal cells is rare in mantle cell lymphoma. Because of the presence of CCND1 gene rearrangement and cyclin D1 positive monoclonal B lymphoma cells in the BM, a diagnosis of leukemic phase of a small cell variant of mantle cell lymphoma was rendered.

Blood Res
Volume 59 2024

Stats or Metrics

Share this article on

  • line

Blood Research

pISSN 2287-979X
eISSN 2288-0011
qr-code Download